BAG2 Antikörper (C-Term)

Produktnummer ABIN630239

Produktdetails anti-BAG2 Antikörper

Target: BAG2 (BCL2-Associated Athanogene 2 (BAG2))

Bindungsspezifität: C-Term

Reaktivität: Human, Ratte, Maus, Zebrafisch (Danio rerio), Hund

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser BAG2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC)

Spezifität: BAG2 antibody was raised against the C terminal of BAG2

Aufreinigung: Purified

Immunogen: BAG2 antibody was raised using the C terminal of BAG2 corresponding to a region with amino acids VDQKFQSIVIGCALEDQKKIKRRLETLLRNIENSDKAIKLLEHSKGAGSK

Anwendungsinformationen

Applikationshinweise: WB: 1.25 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

BAG2 Blocking Peptide, catalog no. 33R-9474, is also available for use as a blocking control in assays to test for specificity of this BAG2 antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of BAG2 antibody in PBS

Konzentration: Lot specific

Buffer: PBS

Handhabung: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Details zu BAG2

Target: BAG2 (BCL2-Associated Athanogene 2 (BAG2))

Andere Bezeichnung: BAG2 (BAG2 Produkte)

Synonyme: bag2 antikoerper, MGC89300 antikoerper, BAG2 antikoerper, ATBAG2 antikoerper, BCL-2-associated athanogene 2 antikoerper, MTG10.13 antikoerper, MTG10_13 antikoerper, BAG-2 antikoerper, dJ417I1.2 antikoerper, zgc:64195 antikoerper, 2610042A13Rik antikoerper, BC016230 antikoerper, BCL2 associated athanogene 2 antikoerper, BCL-2-associated athanogene 2 antikoerper, BCL2-associated athanogene 2 antikoerper, Bcl2-associated athanogene 2 antikoerper, bag2 antikoerper, BAG2 antikoerper, Bag2 antikoerper

Hintergrund: BAG proteins compete with Hip for binding to the Hsc70/Hsp70 ATPase domain and promote substrate release. All the BAG proteins have an approximately 45-amino acid BAG domain near the C terminus but differ markedly in their N-terminal regions. The predicted BAG2 protein contains 211 amino acids. The BAG domains of BAG1, BAG2, and BAG3 interact specifically with the Hsc70 ATPase domain in vitro and in mammalian cells. All 3 proteins bind with high affinity to the ATPase domain of Hsc70 and inhibit its chaperone activity in a Hip-repressible manner.

Molekulargewicht: 23 kDa (MW of target protein)